Journal of AIDS and HIV Treatment,
Год журнала:
2024,
Номер
6(1), С. 44 - 53
Опубликована: Янв. 1, 2024
Background:
HIV/AIDS
remains
a
major
global
public
health
challenge
despite
significant
progress
in
treatment.
New
infections
and
HIV-related
deaths
persist,
fueled
by
disparities
prevention
care
access.
Purpose:
This
review
synthesizes
recent
advances
across
key
domains
-
from
vaccine
development
to
novel
treatments
omics
approaches
–
that
collectively
hold
promise
for
ending
the
pandemic.
Main
body:
Multiple
innovative
HIV
platforms
are
now
early-phase
trials,
including
mRNA
vaccines
as
well
conserved
epitope
mosaic
constructs
broader
immunogenicity.
Long-acting
injectable
antiretrovirals
represent
milestone
treatment,
while
gene
editing
techniques
offer
future
curative
potential.
Leveraging
multi-omics
data
through
genomics,
transcriptomics,
proteomics,
metabolomics
provides
systems-level
insights
into
viral
persistence
new
therapeutic
opportunities.
The
gut
microbiome
is
increasingly
recognized
mediator
of
progression,
spurring
research
probiotic/prebiotic
supplementation
fecal
transplantation.
Across
these
domains,
integration
artificial
intelligence
machine
learning
will
likely
accelerate
discovery.
Conclusion:
Despite
past
setbacks,
cure
effort
has
renewed
momentum.
Translating
emerging
tools
like
long-acting
profiling
clinical
application
could
bend
pandemic’s
trajectory.
Innovation
must
be
paired
with
ensuring
equitable
access
maximize
impact.
Advances in Clinical Toxicology,
Год журнала:
2024,
Номер
9(1), С. 1 - 8
Опубликована: Янв. 1, 2024
Background:
Hepatocellular
carcinoma
(HCC)
is
a
prevalent
liver
cancer
with
major
risk
factors
being
hepatitis
viral
infections,
alcohol,
non-alcoholic
fatty
disease,
and
aflatoxin
exposure.
Both
genotoxic
non-genotoxic
agents
can
induce
HCC
through
mechanisms
involving
DNA
damage,
oxidative
stress,
chronic
inflammation,
disrupted
signaling
pathways
like
MAPK/ERK,
PI3K/AKT,
WNT/β-catenin
PPARα.
While
rodent
assays
are
utilized
to
detect
potential
chemical
hepatocarcinogens,
species
differences
in
PPARα
CAR/PXR
activation
impact
human
assessment.
Purpose:
This
analysis
provides
an
updated,
critical
examination
of
concordance
hepatic
carcinogenesis
inform
safety
assessment
tumor
findings.
Main
Body:
Rodent
including
2-year
bioassays,
transgenic
models,
short-term
studies
tumors
lifetime
exposure
or
early
biomarkers.
However,
rodent-specific
activation,
along
hepatitis,
highlight
key
interspecies
differences.
Determining
mode
action
relevance
requires
evaluating
mechanistic
validity
pivotal
events
leading
across
species.
Non-genotoxic
compounds
eliciting
activate
PPARα,
CAR/PXR,
other
triggering
increased
cell
replication;
but
downstream
may
differ
liver.
Understanding
applicability
these
humans
as
well
incorporating
into
experimental
models
for
accurate
Conclusion:
In
summary,
elucidating
conserved
versus
divergent
molecular
between
rodents
essential
appropriately
interpreting
findings
safeguarding
health
science-based
frameworks
regulatory
decision-making
processes
around
hazards.
Archives of Pharmacology and Therapeutics,
Год журнала:
2024,
Номер
6(1), С. 27 - 33
Опубликована: Янв. 1, 2024
Background:
Schisandra
chinensis
is
a
traditional
Chinese
herbal
medicine
that
has
been
used
for
centuries
liver
health.
The
active
lignans
in
Schisandra,
including
schisandrin
and
gomisins,
have
exhibited
anti-inflammatory,
antioxidant,
hepatoprotective
properties
preliminary
studies.
With
rising
rates
of
chronic
diseases
globally,
there
interest
the
potential
therapeutic
role
Schisandra.
Purpose:
To
comprehensively
review
current
evidence
treating
injury
disease
synthesize
implications
future
human
research.
Main
body:
extracts
decreased
inflammatory
cytokines
oxidative
stress
markers
increased
endogenous
antioxidant
activity
animal
models,
suggesting
utility
mitigating
inflammation
damage.
Additional
preclinical
studies
demonstrated
attenuated
enzyme
levels,
necrosis,
fibrosis
progression
chemical-induced
hepatotoxicity
with
treatment.
Enhanced
cytochrome
P450
activity,
glutathione
production,
glycogen
synthesis
were
also
observed,
improving
detoxification
regeneration
capacity.
Small
trials
hepatitis
nonalcoholic
fatty
showed
improved
enzymes
symptoms
supplementation
but
limited
quality
sample
size.
Conclusion:
biologically
relevant
mechanisms
warrant
further
research
on
its
as
phytotherapy.
Well-designed,
large-scale
clinical
are
needed
to
establish
efficacy
safety
applications.
Bulletin of the National Research Centre/Bulletin of the National Research Center,
Год журнала:
2024,
Номер
48(1)
Опубликована: Апрель 19, 2024
Abstract
Background
Type
1
diabetes
(T1D)
is
an
autoimmune
disease
leading
to
destruction
of
insulin-producing
pancreatic
beta
cells.
Both
genetic
and
environmental
factors
contribute
pathogenesis.
The
incidence
T1D
increasing
worldwide,
with
significant
geographic
ethnic
variations.
Patients
present
symptoms
hyperglycemia
complications.
Main
body
In
T1D,
autoreactive
T
cells
autoantibodies
destroy
cells,
causing
insulin
deficiency.
Exogenous
therapy
essential
but
cannot
replicate
normal
physiology.
Management
requires
intensive
lifestyle
education
on
diet,
exercise,
glucose
monitoring
avoiding
complications,
in
addition
insulin.
Novel
therapies
like
immunotherapy,
cell
transplantation,
artificial
pancreas
devices
AI
algorithms
aim
improve
care.
Strategies
for
reversing
involve
combination
immunotherapies
block
autoimmunity
regenerate
via
stem
or
xenotransplantation.
Conclusion
While
type
remains
challenging,
ongoing
research
provides
hope.
Elucidating
individualized
mechanisms
translating
findings
into
precision
prevention
treatment
approaches
are
critical
improving
long-term
outcomes.
Innovative
multi-targeted
may
fundamentally
change
the
trajectory
T1D.
Jurnal Online Informatika,
Год журнала:
2024,
Номер
9(1), С. 70 - 79
Опубликована: Апрель 26, 2024
This
study
aims
to
provide
an
overview
of
the
current
state-of-the-art
applications
artificial
intelligence
(AI)
and
machine
learning
in
management
hepatocellular
carcinoma
(HCC),
explore
future
directions
for
continued
progress
this
emerging
field.
is
a
comprehensive
literature
review
that
synthesizes
recent
findings
advancements
application
AI
techniques
across
various
aspects
HCC
care,
including
screening
early
detection,
diagnosis
staging,
prognostic
modeling,
treatment
planning,
interventional
guidance,
monitoring
response.
The
draws
upon
wide
range
published
research
studies,
focusing
on
integration
with
diverse
data
sources,
such
as
medical
imaging,
clinical
data,
genomics,
other
multimodal
information.
results
demonstrate
AI-based
systems
have
shown
promise
improving
accuracy
efficiency
screening,
diagnosis,
tumor
characterization
compared
traditional
methods.
Machine
models
integrating
clinical,
genomic
outperformed
conventional
staging
predicting
survival
recurrence
risk.
recommendation
potential
optimize
personalized
therapy
selection,
while
augmented
reality
can
guide
procedures
real-time.
Moreover,
longitudinal
may
enhance
assessment
response
monitoring.
Despite
these
promising
findings,
highlights
need
rigorous
multicenter
prospective
validation
standardized
datasets,
thoughtful
consideration
ethical
implications
before
widespread
implementation
technologies
management.
Bulletin of the National Research Centre/Bulletin of the National Research Center,
Год журнала:
2024,
Номер
48(1)
Опубликована: Сен. 12, 2024
Abstract
Background
Acute
cholecystitis,
inflammation
of
the
gallbladder,
can
lead
to
serious
complications
if
not
promptly
diagnosed
and
managed.
Conventional
therapies
have
limitations,
necessitating
newer
personalized
approaches.
Main
body
abstract
This
review
examines
recent
advances
transforming
cholecystitis
care.
Diagnostically,
molecular
techniques
like
next-generation
sequencing
rapidly
identify
causative
microbes
from
gallbladder
specimens,
enabling
targeted
antimicrobial
therapy.
Regarding
treatment,
phage
therapy
uses
viruses
lyse
pathogenic
bacteria.
RNA
interference
CRISPR-Cas9
gene
editing
silence
microbial
virulence
factors.
Probiotics
competitively
exclude
pathogens.
Robotics
fluorescence
imaging
refine
surgical
techniques.
Additional
emerging
modalities
include
biosensors
detecting
inflammatory
mediators,
regenerative
tissue
engineering
using
stem
cells,
artificial
intelligence
for
real-time
decision
support.
However,
optimal
integration
novel
technologies
with
current
best
practices
remains
unknown.
Further
research
is
needed
validate
optimize
diagnostics
therapeutics
cholecystitis.
Short
conclusions
Advances
in
sequencing,
CRISPR
editing,
robotics,
other
biotechnologies
promise
transform
precision
management
when
thoughtfully
implemented.
controlled
trials
are
still
required
define
conventional
supportive
care
antibiotics.
Egyptian Journal of Medical Human Genetics,
Год журнала:
2025,
Номер
26(1)
Опубликована: Март 20, 2025
Abstract
Background
Posttraumatic
stress
disorder
(PTSD)
affects
approximately
8%
of
the
US
population,
with
varying
susceptibility
among
individuals
exposed
to
trauma.
While
genetic
factors
contribute
PTSD
risk,
emerging
evidence
suggests
that
epigenetic
mechanisms
play
a
crucial
role
in
translating
environmental
exposures
into
lasting
neurobiological
changes.
Purpose
This
review
provides
comprehensive
analysis
cutting-edge
research
on
PTSD,
particular
emphasis
novel
findings
regarding
resilience
and
mechanisms.
We
explore
recent
technological
advances
their
applications
understanding
pathophysiology.
Main
body
Advanced
epigenomic
approaches
have
revealed
complex
interactions
between
DNA
methylation,
histone
modifications,
non-coding
RNAs
PTSD.
Novel
highlight
cell
type-specific
signatures
temporal
dynamics
following
trauma
exposure.
Single-cell
studies
identified
previously
unknown
cellular
heterogeneity
responses.
Recent
data
modifications
not
only
influence
individual
but
may
also
transgenerational
transmission
effects.
Integrative
multi-omics
new
insights
molecular
networks
underlying
vulnerability.
Conclusion
unprecedented
complexity
These
open
avenues
for
personalized
interventions
based
profiles
suggest
therapeutic
strategies
targeting
modifications.
enhanced
has
significant
implications
risk
assessment,
prevention,
treatment.
Graphical
abstract
Alcohol-related
liver
disease
(ALD)
is
a
significant
global
health
concern,
contributing
substantially
to
liver-related
morbidity
and
mortality.
Liver
stiffness
measurement
(LSM)
has
emerged
as
non-invasive,
reliable
method
for
assessing
fibrosis
cirrhosis
in
ALD.
This
review
examines
the
role
of
LSM
predicting
monitoring
risk
decompensation
mortality
ALD
patients.
We
conducted
comprehensive
analysis
recent
literature
on
techniques,
including
transient
elastography,
magnetic
resonance
acoustic
radiation
force
impulse
imaging,
shear
wave
elastography.
The
focused
pathophysiology
ALD,
predictive
value
hepatic
mortality,
its
use
progression
treatment
response.
demonstrates
strong
power
with
values
above
20–25
kPa
generally
associated
increased
risk.
Serial
measurements
provide
valuable
insights
into
effects
alcohol
abstinence
or
relapse.
Integration
other
biomarkers
prognostic
models
enhances
stratification
clinical
decision-making.
However,
challenges
remain
standardizing
techniques
establishing
ALD-specific
cutoff
values.
represents
advance
management,
offering
dynamic
repeatable
measure
health.
Its
ability
predict
outcomes
monitor
response
makes
it
tool
guiding
care.
Future
research
should
focus
standardization,
multimodal
approaches
combining
biomarkers,
application
artificial
intelligence
data
further
improve
utility
management.
Egyptian Liver Journal,
Год журнала:
2024,
Номер
14(1)
Опубликована: Ноя. 12, 2024
Abstract
Background
Polyploidization,
a
process
where
cells
acquire
additional
chromosome
sets,
is
unique
characteristic
of
hepatocytes.
This
has
been
increasingly
recognized
as
an
adaptive
mechanism
for
maintaining
liver
function
during
aging,
period
characterized
by
cellular
senescence,
DNA
damage,
and
metabolic
dysregulation.
Purpose
review
explores
the
molecular
mechanisms
underlying
hepatocyte
polyploidization
its
potential
role
in
promoting
resilience
against
aging-related
decline
function.
We
assess
how
polyploid
hepatocytes
contribute
to
genomic
stability,
stress
resistance,
adaptation,
highlighting
their
relevance
aging.
Main
body
Hepatocyte
occurs
through
such
cytokinesis
failure
endoreplication,
leading
binuclear
or
mononuclear
cells.
Polyploid
exhibit
enhanced
repair
capacity,
which
helps
mitigate
accumulation
age-related
damage.
The
increased
gene
dosage
facilitates
better
responses,
particularly
oxidative
genotoxic
insults.
Metabolic
adaptations,
including
xenobiotic
metabolism
lipid
regulation,
further
support
liver’s
ability
maintain
homeostasis
Additionally,
demonstrate
altered
epigenetic
landscapes
proteostasis
mechanisms,
contributing
improved
reduced
susceptibility
senescence.
These
adaptations
collectively
enhance
structural
challenges.
Conclusion
represents
critical
protective
that
safeguard
instability,
dysfunction,
stress.
Understanding
pathways
driving
could
pave
way
novel
therapeutic
strategies
combat
disorders
health
span.
Graphical